All
I found this on the net today at last they might be listing to us.
June 2002 -- The 21st Joint Meeting of the British Endocrine Societies in April
2002 was the occasion for a surprising about-face from Anthony Toft, one of the
UK's most prominent thyroid experts, as he expressed an apparent shift in
opinion on the use of T3 as part of hypothyroidism treatment.
Toft went from being a sometimes adamant opponent of the use of supplemental T3
as a thyroid therapy, to indicating that the addition of T3 may in fact be the
superior therapy. According to Toft's presentation at the meeting, animal
thyroid extract was introduced in the late 1800s. He claims that
due to "variable potency," it was widely replaced by synthetic T4 from the
1960s, but that doses tended to be higher - in the 200-400 micrograms daily
level - as a way to compensate for lack of T3, because a "significant minority
of patients only achieve the desired sense of well-being if serum TSH
is suppressed." According to Toft, a dose of 100-150 mcg. daily would in reality
be enough to restore TSH alone to normal levels. The elevated dose needed for
better patient well-being, however, increases the risk of osteoporosis, atrial
fibrillation, and heart disease. According to Toft: patients
who became hypothyroid after hyperthyroidism who take a T4-only drug gain more
weight than those who do not become hypothyroid. in studies of hypothyroid
rats, it was found that it was possible to restore universal tissue euthyroidism
(normal circulating thyroid hormone levels) only using a
combination of T3 and T4 and not on T4 alone in patients on long-term T4
therapy who were given an equivalent combination of T3 and T4 scored better in
various neurological and psychological tests. According to Toft, "It would
appear that the treatment of hypothyroidism is about to come full
circle." It would appear that the treatment of hypothyroidism is about to come
full circle... --Anthony Toft This is a dramatic departure from Toft's
editorial, in the February 11, 1999 isssue of the New England Journal of
Medicine <http://www.thyroid-info.com/articles/t3drugsnejm.htm
"Thyroid Hormone Replacement - One Hormone or Two?" This editorial accompanied
the groundbreaking research published in that same issue of the journal that
found that the majority of patients feel best with the addition of T3, findings
which were controversial to endocrinologists, but already
well-known to patients and holistic thyroid experts. In his editorial, Toft
claimed that one of the reasons physicians should not add the T3 hormone to the
treatment until study findings are confirmed by additional research, was, as he
claimed: ...most, if not all, of the currently available
combined preparations of thyroid hormones contain an excess of triiodothyronine
as compared with thyroxine. To say that this was a reason not to advocate the
use of T3 was highly illogical. It is true that Thyrolar and the natural
desiccated T4/T3 products (such as Armour and Naturethroid) have a
higher percentage of T3 than that used by the researchers in their study. But
Cytomel, a T3-only drug, was and is readily available, and compounding
pharmacies almost anywhere can easily prepare time-released T3. In his
editorial, Toft also claimed that the desiccated thyroid extracts were
"considered obsolete for some time by all but a few practitioners, who are often
thought by their colleagues to be practicing on the fringes of medicine." Toft
also argued that the majority of patients taking thyroxine "have no complaints
about their medication." Here, Toft was actually directly
contradicting the findings of iresearch conducted by the Thyroid Foundation of
America that showed that the majority of post-Graves' disease hypothyroid
patients still suffered a variety of symptoms when on levothyroxine. Until this
seeming reversal of his previous opinions, Dr. Toft has been a
quite active proponent of the "normal range constitutes treatment" philosophy of
hypothyroid management that has left so many countless millions of patients
undiagnosed, undertreated, or maltreated. It's encouraging to see that someone
who was so clearly not in tune with the needs of thyroid
patients has "seen the light" so to speak, and realizes that sometimes, patients
do know best, and that some of the best patient care may actually be taking
place on the "fringes of medicine!" Sources: Toft, Anthony. "T3/T4
combination therapy," Endocrine Abstracts , 3 S40,
<http://www.endocrine-abstracts.org/ea/0003/ea0003s40.htm
"Thyroid Hormone Replacement - One Hormone or Two?" New England Journal of
Medicine, Volume 340:468-470 February 11, 1999 Number 6. Bunevicius, et. al.,
"Effects of Thyroxine as Compared with Thyroxine plus
Triiodothyronine in Patients with Hypothyroidism" New England Journal of
Medicine, Volume 340: February 11, 1999 Number 6. (For more information, read:
T3 Triiodothyronine Drugs Improve Quality of Life for Hypothyroidism
<http://www.thyroid-info.com/articles/t3drugsnejm.htm
**********************************************************************
This message may contain information which is confidential or privileged.
If you are not the intended recipient, please advise the sender immediately
by reply e-mail and delete this message and any attachments
without retaining a copy.
**********************************************************************